Sanomics (Thailand) Ltd.

Company Name

Sanomics (Thailand) Ltd.

Business Sector

Genetic screening tests for cancer patients, Preimplanation genetic screening (PGS)

Telephone no.

+66 2 105 4670

Fax no.

+66 2 103 2291

Email address

contact.us.thai@sanomics.com

Company background

Founded in Hong Kong in 2015, “Patient First” is Sanomics Limited’s principle. Sanomics specialized in providing liquid biopsy and tissue based genetic diagnostics for cancer patients, helping doctors decide personalized cancer soluctions for patients. Focusing on lung and women cancer, Sanomics’ cancer screening services covers both somatic mutation (cannot be passed on to offspring) and germline mutations (can be passed on to offspring).
Sanomics adopts Droplet Digital Polymerase Chain Reaction (ddPCR), Next Generation Sequencing (NGS) technology to complete Comprehensive Genomic Profiling (CGP) and Real-time Polymerase Chain Reaction (Real-time PCR).
-The first type of service provides genetic analysis using ddPCR technology, enabling a simple and speedy process. For example, one of our services “p-EGFR®” detects the EGFR gene mutation which causes lung cancer.
-The second type of service uses NGS technology, which can be used to test a large gene panel analyzing the situation and determining if there are any gene mutations. It covers more genes than the first type of service. For instance, OncoSnap™ tumor profiling test screens genetic alterations in tomour samples. It can be used to detect 130 genes which will cause breast cancer, ovarian cancer, skin cancer, colorectal cancer, bone cancer, and brain cancer, etc. Another example is BRCA Zoom™ genetic test, which can detect the mutations of BRCAI and BRCA2 genes which may lead to breast cancer, ovarian cancer and prostate cancer.
– The third type of service uses Real-time PCR, which can test multiple genes within a short time. Fore example, OncoSnap Nonet™ can screen the 9 frequent mutation genes related to lung cancer with 1 test.
Being one of the market leaders in cancer genomics technology in Hong Kong and Asia Pacific, Sanomics is committed to bring the latest and best genomics technologies to the healthcare industry in Hong Kong, China and other Asian countries, and help the oncologists in cancer management and research.
No. 4, 4/5 Unit 1503 Zen Tower, 15th Floor, Ratchadamri Road, Pathumwan, Bangkok 10330
https://www.sanomics.com

Representative(s)’ name

Bobby Zhong

Position of rep

General Manager

Photos of rep

Email of rep

bobby.zhong@sanomics.com

Speak Your Mind

*